nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—MTHFR—glaucoma	0.354	1	CbGaD
Methotrexate—AOX1—Brimonidine—glaucoma	0.249	0.759	CbGbCtD
Methotrexate—SLC22A6—Methazolamide—glaucoma	0.0316	0.0963	CbGbCtD
Methotrexate—SLC22A6—Acetazolamide—glaucoma	0.0253	0.077	CbGbCtD
Methotrexate—ABCB1—Timolol—glaucoma	0.012	0.0365	CbGbCtD
Methotrexate—ABCB1—Clonidine—glaucoma	0.0102	0.031	CbGbCtD
Methotrexate—SLC19A1—Treprostinil—Latanoprost—glaucoma	0.00225	0.646	CbGdCrCtD
Methotrexate—SLC22A8—optic choroid—glaucoma	0.00186	0.122	CbGeAlD
Methotrexate—FOLR1—eye—glaucoma	0.00145	0.0951	CbGeAlD
Methotrexate—FPGS—Treprostinil—Latanoprost—glaucoma	0.00123	0.354	CbGdCrCtD
Methotrexate—Tetrahydrofolic acid—MTHFR—glaucoma	0.00107	0.5	CrCbGaD
Methotrexate—Folic Acid—MTHFR—glaucoma	0.00107	0.5	CrCbGaD
Methotrexate—SLC46A1—eye—glaucoma	0.000982	0.0643	CbGeAlD
Methotrexate—FPGS—retina—glaucoma	0.000842	0.0551	CbGeAlD
Methotrexate—ATIC—eye—glaucoma	0.000822	0.0538	CbGeAlD
Methotrexate—FPGS—connective tissue—glaucoma	0.000818	0.0536	CbGeAlD
Methotrexate—ATIC—retina—glaucoma	0.000814	0.0533	CbGeAlD
Methotrexate—ATIC—connective tissue—glaucoma	0.000792	0.0518	CbGeAlD
Methotrexate—MTHFR—eye—glaucoma	0.000611	0.04	CbGeAlD
Methotrexate—SLCO3A1—retina—glaucoma	0.000595	0.039	CbGeAlD
Methotrexate—DHFR—eye—glaucoma	0.000552	0.0361	CbGeAlD
Methotrexate—DHFR—retina—glaucoma	0.000547	0.0358	CbGeAlD
Methotrexate—TYMS—connective tissue—glaucoma	0.000537	0.0351	CbGeAlD
Methotrexate—DHFR—connective tissue—glaucoma	0.000531	0.0348	CbGeAlD
Methotrexate—PGD—eye—glaucoma	0.00053	0.0347	CbGeAlD
Methotrexate—PGD—retina—glaucoma	0.000526	0.0344	CbGeAlD
Methotrexate—PGD—connective tissue—glaucoma	0.000511	0.0334	CbGeAlD
Methotrexate—SLC16A1—eye—glaucoma	0.000495	0.0324	CbGeAlD
Methotrexate—SLC16A1—retina—glaucoma	0.000491	0.0321	CbGeAlD
Methotrexate—AOX1—eye—glaucoma	0.000467	0.0306	CbGeAlD
Methotrexate—SLC22A8—eye—glaucoma	0.000374	0.0245	CbGeAlD
Methotrexate—ABCB1—retina—glaucoma	0.00013	0.00851	CbGeAlD
Methotrexate—Eye disorder—Betaxolol—glaucoma	0.000112	0.000556	CcSEcCtD
Methotrexate—Pruritus—Apraclonidine—glaucoma	0.000112	0.000556	CcSEcCtD
Methotrexate—Body temperature increased—Acetazolamide—glaucoma	0.000112	0.000555	CcSEcCtD
Methotrexate—Fatigue—Dorzolamide—glaucoma	0.000112	0.000555	CcSEcCtD
Methotrexate—Tinnitus—Betaxolol—glaucoma	0.000112	0.000555	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000112	0.000554	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Travoprost—glaucoma	0.000112	0.000553	CcSEcCtD
Methotrexate—Fatigue—Travoprost—glaucoma	0.000112	0.000553	CcSEcCtD
Methotrexate—Cardiac disorder—Betaxolol—glaucoma	0.000112	0.000552	CcSEcCtD
Methotrexate—Ill-defined disorder—Clonidine—glaucoma	0.000112	0.000552	CcSEcCtD
Methotrexate—Pain—Dorzolamide—glaucoma	0.000111	0.000551	CcSEcCtD
Methotrexate—Insomnia—Pilocarpine—glaucoma	0.000111	0.00055	CcSEcCtD
Methotrexate—Decreased appetite—Brinzolamide—glaucoma	0.000111	0.00055	CcSEcCtD
Methotrexate—Pain—Travoprost—glaucoma	0.000111	0.000548	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00011	0.000546	CcSEcCtD
Methotrexate—Paraesthesia—Pilocarpine—glaucoma	0.00011	0.000546	CcSEcCtD
Methotrexate—Asthenia—Bimatoprost—glaucoma	0.00011	0.000546	CcSEcCtD
Methotrexate—Fatigue—Brinzolamide—glaucoma	0.00011	0.000546	CcSEcCtD
Methotrexate—Dyspnoea—Pilocarpine—glaucoma	0.00011	0.000542	CcSEcCtD
Methotrexate—Pain—Brinzolamide—glaucoma	0.000109	0.000541	CcSEcCtD
Methotrexate—Somnolence—Pilocarpine—glaucoma	0.000109	0.000541	CcSEcCtD
Methotrexate—Depression—Timolol—glaucoma	0.000109	0.00054	CcSEcCtD
Methotrexate—Angiopathy—Betaxolol—glaucoma	0.000109	0.00054	CcSEcCtD
Methotrexate—Pruritus—Bimatoprost—glaucoma	0.000109	0.000539	CcSEcCtD
Methotrexate—Immune system disorder—Betaxolol—glaucoma	0.000109	0.000538	CcSEcCtD
Methotrexate—Diarrhoea—Apraclonidine—glaucoma	0.000109	0.000537	CcSEcCtD
Methotrexate—Malaise—Clonidine—glaucoma	0.000109	0.000537	CcSEcCtD
Methotrexate—Mediastinal disorder—Betaxolol—glaucoma	0.000108	0.000536	CcSEcCtD
Methotrexate—Dyspepsia—Pilocarpine—glaucoma	0.000108	0.000535	CcSEcCtD
Methotrexate—Chills—Betaxolol—glaucoma	0.000108	0.000534	CcSEcCtD
Methotrexate—Feeling abnormal—Dorzolamide—glaucoma	0.000107	0.000531	CcSEcCtD
Methotrexate—Decreased appetite—Pilocarpine—glaucoma	0.000107	0.000529	CcSEcCtD
Methotrexate—Feeling abnormal—Travoprost—glaucoma	0.000107	0.000528	CcSEcCtD
Methotrexate—Conjunctivitis—Timolol—glaucoma	0.000106	0.000527	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dorzolamide—glaucoma	0.000106	0.000526	CcSEcCtD
Methotrexate—Alopecia—Betaxolol—glaucoma	0.000106	0.000526	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000106	0.000525	CcSEcCtD
Methotrexate—Gastrointestinal pain—Travoprost—glaucoma	0.000106	0.000524	CcSEcCtD
Methotrexate—Feeling abnormal—Brinzolamide—glaucoma	0.000105	0.000522	CcSEcCtD
Methotrexate—Mental disorder—Betaxolol—glaucoma	0.000105	0.000522	CcSEcCtD
Methotrexate—Pain—Pilocarpine—glaucoma	0.000105	0.00052	CcSEcCtD
Methotrexate—Cough—Clonidine—glaucoma	0.000105	0.000519	CcSEcCtD
Methotrexate—Sweating—Timolol—glaucoma	0.000105	0.000519	CcSEcCtD
Methotrexate—Dizziness—Apraclonidine—glaucoma	0.000105	0.000519	CcSEcCtD
Methotrexate—Malnutrition—Betaxolol—glaucoma	0.000105	0.000518	CcSEcCtD
Methotrexate—Erythema—Betaxolol—glaucoma	0.000105	0.000518	CcSEcCtD
Methotrexate—Urticaria—Dorzolamide—glaucoma	0.000103	0.000511	CcSEcCtD
Methotrexate—Epistaxis—Timolol—glaucoma	0.000103	0.000511	CcSEcCtD
Methotrexate—Abdominal pain—Dorzolamide—glaucoma	0.000103	0.000509	CcSEcCtD
Methotrexate—Body temperature increased—Dorzolamide—glaucoma	0.000103	0.000509	CcSEcCtD
Methotrexate—Dysgeusia—Betaxolol—glaucoma	0.000103	0.000507	CcSEcCtD
Methotrexate—Arthralgia—Clonidine—glaucoma	0.000102	0.000507	CcSEcCtD
Methotrexate—Chest pain—Clonidine—glaucoma	0.000102	0.000507	CcSEcCtD
Methotrexate—Abdominal pain—Travoprost—glaucoma	0.000102	0.000507	CcSEcCtD
Methotrexate—Agranulocytosis—Timolol—glaucoma	0.000102	0.000506	CcSEcCtD
Methotrexate—Asthenia—Acetazolamide—glaucoma	0.000102	0.000504	CcSEcCtD
Methotrexate—Dizziness—Bimatoprost—glaucoma	0.000102	0.000503	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000102	0.000503	CcSEcCtD
Methotrexate—Urticaria—Brinzolamide—glaucoma	0.000102	0.000503	CcSEcCtD
Methotrexate—Feeling abnormal—Pilocarpine—glaucoma	0.000101	0.000501	CcSEcCtD
Methotrexate—Discomfort—Clonidine—glaucoma	0.000101	0.000501	CcSEcCtD
Methotrexate—Vomiting—Apraclonidine—glaucoma	0.000101	0.000499	CcSEcCtD
Methotrexate—Gastrointestinal pain—Pilocarpine—glaucoma	0.000101	0.000497	CcSEcCtD
Methotrexate—Hypersensitivity—Brimonidine—glaucoma	0.0001	0.000497	CcSEcCtD
Methotrexate—Dermatitis—Apraclonidine—glaucoma	0.0001	0.000495	CcSEcCtD
Methotrexate—Headache—Apraclonidine—glaucoma	9.95e-05	0.000492	CcSEcCtD
Methotrexate—Confusional state—Clonidine—glaucoma	9.9e-05	0.00049	CcSEcCtD
Methotrexate—Vision blurred—Betaxolol—glaucoma	9.87e-05	0.000488	CcSEcCtD
Methotrexate—Asthenia—Brimonidine—glaucoma	9.78e-05	0.000484	CcSEcCtD
Methotrexate—Infection—Clonidine—glaucoma	9.76e-05	0.000483	CcSEcCtD
Methotrexate—Body temperature increased—Pilocarpine—glaucoma	9.72e-05	0.000481	CcSEcCtD
Methotrexate—Abdominal pain—Pilocarpine—glaucoma	9.72e-05	0.000481	CcSEcCtD
Methotrexate—Ill-defined disorder—Betaxolol—glaucoma	9.72e-05	0.000481	CcSEcCtD
Methotrexate—Diarrhoea—Acetazolamide—glaucoma	9.72e-05	0.000481	CcSEcCtD
Methotrexate—Rash—Bimatoprost—glaucoma	9.7e-05	0.00048	CcSEcCtD
Methotrexate—Dermatitis—Bimatoprost—glaucoma	9.7e-05	0.00048	CcSEcCtD
Methotrexate—Anaemia—Betaxolol—glaucoma	9.68e-05	0.000479	CcSEcCtD
Methotrexate—Pruritus—Brimonidine—glaucoma	9.64e-05	0.000477	CcSEcCtD
Methotrexate—Headache—Bimatoprost—glaucoma	9.64e-05	0.000477	CcSEcCtD
Methotrexate—Nervous system disorder—Clonidine—glaucoma	9.63e-05	0.000476	CcSEcCtD
Methotrexate—Thrombocytopenia—Clonidine—glaucoma	9.62e-05	0.000476	CcSEcCtD
Methotrexate—Hypersensitivity—Dorzolamide—glaucoma	9.59e-05	0.000474	CcSEcCtD
Methotrexate—Hypersensitivity—Travoprost—glaucoma	9.55e-05	0.000472	CcSEcCtD
Methotrexate—Skin disorder—Clonidine—glaucoma	9.54e-05	0.000472	CcSEcCtD
Methotrexate—Hyperhidrosis—Clonidine—glaucoma	9.49e-05	0.00047	CcSEcCtD
Methotrexate—Visual impairment—Timolol—glaucoma	9.48e-05	0.000469	CcSEcCtD
Methotrexate—Malaise—Betaxolol—glaucoma	9.45e-05	0.000467	CcSEcCtD
Methotrexate—Nausea—Apraclonidine—glaucoma	9.43e-05	0.000466	CcSEcCtD
Methotrexate—Hypersensitivity—Brinzolamide—glaucoma	9.43e-05	0.000466	CcSEcCtD
Methotrexate—Vertigo—Betaxolol—glaucoma	9.41e-05	0.000466	CcSEcCtD
Methotrexate—Dizziness—Acetazolamide—glaucoma	9.39e-05	0.000464	CcSEcCtD
Methotrexate—Anorexia—Clonidine—glaucoma	9.36e-05	0.000463	CcSEcCtD
Methotrexate—Asthenia—Dorzolamide—glaucoma	9.34e-05	0.000462	CcSEcCtD
Methotrexate—Asthenia—Travoprost—glaucoma	9.3e-05	0.00046	CcSEcCtD
Methotrexate—Pruritus—Dorzolamide—glaucoma	9.21e-05	0.000455	CcSEcCtD
Methotrexate—Eye disorder—Timolol—glaucoma	9.19e-05	0.000454	CcSEcCtD
Methotrexate—Asthenia—Brinzolamide—glaucoma	9.18e-05	0.000454	CcSEcCtD
Methotrexate—Hypotension—Clonidine—glaucoma	9.18e-05	0.000454	CcSEcCtD
Methotrexate—Pruritus—Travoprost—glaucoma	9.17e-05	0.000453	CcSEcCtD
Methotrexate—Tinnitus—Timolol—glaucoma	9.17e-05	0.000453	CcSEcCtD
Methotrexate—Cough—Betaxolol—glaucoma	9.14e-05	0.000452	CcSEcCtD
Methotrexate—Nausea—Bimatoprost—glaucoma	9.14e-05	0.000452	CcSEcCtD
Methotrexate—Cardiac disorder—Timolol—glaucoma	9.13e-05	0.000451	CcSEcCtD
Methotrexate—Hypersensitivity—Pilocarpine—glaucoma	9.06e-05	0.000448	CcSEcCtD
Methotrexate—Pruritus—Brinzolamide—glaucoma	9.05e-05	0.000448	CcSEcCtD
Methotrexate—Vomiting—Acetazolamide—glaucoma	9.03e-05	0.000447	CcSEcCtD
Methotrexate—Dizziness—Brimonidine—glaucoma	9.01e-05	0.000446	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Clonidine—glaucoma	8.95e-05	0.000443	CcSEcCtD
Methotrexate—Angiopathy—Timolol—glaucoma	8.92e-05	0.000441	CcSEcCtD
Methotrexate—Arthralgia—Betaxolol—glaucoma	8.92e-05	0.000441	CcSEcCtD
Methotrexate—Chest pain—Betaxolol—glaucoma	8.92e-05	0.000441	CcSEcCtD
Methotrexate—Myalgia—Betaxolol—glaucoma	8.92e-05	0.000441	CcSEcCtD
Methotrexate—Diarrhoea—Dorzolamide—glaucoma	8.91e-05	0.00044	CcSEcCtD
Methotrexate—Headache—Acetazolamide—glaucoma	8.9e-05	0.00044	CcSEcCtD
Methotrexate—Insomnia—Clonidine—glaucoma	8.88e-05	0.000439	CcSEcCtD
Methotrexate—Immune system disorder—Timolol—glaucoma	8.88e-05	0.000439	CcSEcCtD
Methotrexate—Diarrhoea—Travoprost—glaucoma	8.87e-05	0.000439	CcSEcCtD
Methotrexate—Mediastinal disorder—Timolol—glaucoma	8.86e-05	0.000438	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	8.86e-05	0.000438	CcSEcCtD
Methotrexate—Asthenia—Pilocarpine—glaucoma	8.82e-05	0.000436	CcSEcCtD
Methotrexate—Paraesthesia—Clonidine—glaucoma	8.82e-05	0.000436	CcSEcCtD
Methotrexate—Discomfort—Betaxolol—glaucoma	8.81e-05	0.000436	CcSEcCtD
Methotrexate—Dyspnoea—Clonidine—glaucoma	8.76e-05	0.000433	CcSEcCtD
Methotrexate—Diarrhoea—Brinzolamide—glaucoma	8.76e-05	0.000433	CcSEcCtD
Methotrexate—Somnolence—Clonidine—glaucoma	8.73e-05	0.000432	CcSEcCtD
Methotrexate—Pruritus—Pilocarpine—glaucoma	8.7e-05	0.00043	CcSEcCtD
Methotrexate—Alopecia—Timolol—glaucoma	8.69e-05	0.00043	CcSEcCtD
Methotrexate—Confusional state—Betaxolol—glaucoma	8.62e-05	0.000426	CcSEcCtD
Methotrexate—Mental disorder—Timolol—glaucoma	8.61e-05	0.000426	CcSEcCtD
Methotrexate—Dizziness—Dorzolamide—glaucoma	8.61e-05	0.000426	CcSEcCtD
Methotrexate—Rash—Brimonidine—glaucoma	8.59e-05	0.000425	CcSEcCtD
Methotrexate—Dermatitis—Brimonidine—glaucoma	8.59e-05	0.000425	CcSEcCtD
Methotrexate—Dizziness—Travoprost—glaucoma	8.57e-05	0.000424	CcSEcCtD
Methotrexate—Malnutrition—Timolol—glaucoma	8.56e-05	0.000423	CcSEcCtD
Methotrexate—Erythema—Timolol—glaucoma	8.56e-05	0.000423	CcSEcCtD
Methotrexate—Headache—Brimonidine—glaucoma	8.54e-05	0.000422	CcSEcCtD
Methotrexate—Decreased appetite—Clonidine—glaucoma	8.54e-05	0.000422	CcSEcCtD
Methotrexate—Infection—Betaxolol—glaucoma	8.5e-05	0.00042	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Clonidine—glaucoma	8.48e-05	0.000419	CcSEcCtD
Methotrexate—Fatigue—Clonidine—glaucoma	8.47e-05	0.000419	CcSEcCtD
Methotrexate—Dizziness—Brinzolamide—glaucoma	8.46e-05	0.000419	CcSEcCtD
Methotrexate—Nausea—Acetazolamide—glaucoma	8.43e-05	0.000417	CcSEcCtD
Methotrexate—Diarrhoea—Pilocarpine—glaucoma	8.42e-05	0.000416	CcSEcCtD
Methotrexate—Pain—Clonidine—glaucoma	8.4e-05	0.000415	CcSEcCtD
Methotrexate—Nervous system disorder—Betaxolol—glaucoma	8.39e-05	0.000415	CcSEcCtD
Methotrexate—Dysgeusia—Timolol—glaucoma	8.38e-05	0.000415	CcSEcCtD
Methotrexate—Thrombocytopenia—Betaxolol—glaucoma	8.37e-05	0.000414	CcSEcCtD
Methotrexate—Skin disorder—Betaxolol—glaucoma	8.31e-05	0.000411	CcSEcCtD
Methotrexate—Vomiting—Dorzolamide—glaucoma	8.28e-05	0.000409	CcSEcCtD
Methotrexate—Hyperhidrosis—Betaxolol—glaucoma	8.27e-05	0.000409	CcSEcCtD
Methotrexate—Rash—Dorzolamide—glaucoma	8.21e-05	0.000406	CcSEcCtD
Methotrexate—Dermatitis—Dorzolamide—glaucoma	8.2e-05	0.000406	CcSEcCtD
Methotrexate—Rash—Travoprost—glaucoma	8.17e-05	0.000404	CcSEcCtD
Methotrexate—Dermatitis—Travoprost—glaucoma	8.16e-05	0.000404	CcSEcCtD
Methotrexate—Headache—Dorzolamide—glaucoma	8.15e-05	0.000403	CcSEcCtD
Methotrexate—Anorexia—Betaxolol—glaucoma	8.15e-05	0.000403	CcSEcCtD
Methotrexate—Vomiting—Brinzolamide—glaucoma	8.14e-05	0.000402	CcSEcCtD
Methotrexate—Dizziness—Pilocarpine—glaucoma	8.13e-05	0.000402	CcSEcCtD
Methotrexate—Headache—Travoprost—glaucoma	8.12e-05	0.000402	CcSEcCtD
Methotrexate—Nausea—Brimonidine—glaucoma	8.1e-05	0.0004	CcSEcCtD
Methotrexate—Feeling abnormal—Clonidine—glaucoma	8.09e-05	0.0004	CcSEcCtD
Methotrexate—Rash—Brinzolamide—glaucoma	8.07e-05	0.000399	CcSEcCtD
Methotrexate—Vision blurred—Timolol—glaucoma	8.07e-05	0.000399	CcSEcCtD
Methotrexate—Dermatitis—Brinzolamide—glaucoma	8.06e-05	0.000399	CcSEcCtD
Methotrexate—Gastrointestinal pain—Clonidine—glaucoma	8.03e-05	0.000397	CcSEcCtD
Methotrexate—Headache—Brinzolamide—glaucoma	8.02e-05	0.000396	CcSEcCtD
Methotrexate—Hypotension—Betaxolol—glaucoma	7.99e-05	0.000395	CcSEcCtD
Methotrexate—Vomiting—Pilocarpine—glaucoma	7.82e-05	0.000387	CcSEcCtD
Methotrexate—Urticaria—Clonidine—glaucoma	7.8e-05	0.000386	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Betaxolol—glaucoma	7.79e-05	0.000385	CcSEcCtD
Methotrexate—Abdominal pain—Clonidine—glaucoma	7.76e-05	0.000384	CcSEcCtD
Methotrexate—Body temperature increased—Clonidine—glaucoma	7.76e-05	0.000384	CcSEcCtD
Methotrexate—Rash—Pilocarpine—glaucoma	7.75e-05	0.000384	CcSEcCtD
Methotrexate—Dermatitis—Pilocarpine—glaucoma	7.75e-05	0.000383	CcSEcCtD
Methotrexate—Insomnia—Betaxolol—glaucoma	7.73e-05	0.000383	CcSEcCtD
Methotrexate—Nausea—Dorzolamide—glaucoma	7.73e-05	0.000382	CcSEcCtD
Methotrexate—Headache—Pilocarpine—glaucoma	7.7e-05	0.000381	CcSEcCtD
Methotrexate—Nausea—Travoprost—glaucoma	7.7e-05	0.000381	CcSEcCtD
Methotrexate—Vertigo—Timolol—glaucoma	7.69e-05	0.00038	CcSEcCtD
Methotrexate—Paraesthesia—Betaxolol—glaucoma	7.68e-05	0.00038	CcSEcCtD
Methotrexate—Dyspnoea—Betaxolol—glaucoma	7.62e-05	0.000377	CcSEcCtD
Methotrexate—Nausea—Brinzolamide—glaucoma	7.6e-05	0.000376	CcSEcCtD
Methotrexate—Dyspepsia—Betaxolol—glaucoma	7.53e-05	0.000372	CcSEcCtD
Methotrexate—Cough—Timolol—glaucoma	7.47e-05	0.000369	CcSEcCtD
Methotrexate—Decreased appetite—Betaxolol—glaucoma	7.43e-05	0.000368	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Betaxolol—glaucoma	7.38e-05	0.000365	CcSEcCtD
Methotrexate—Fatigue—Betaxolol—glaucoma	7.37e-05	0.000365	CcSEcCtD
Methotrexate—Pain—Betaxolol—glaucoma	7.31e-05	0.000362	CcSEcCtD
Methotrexate—Nausea—Pilocarpine—glaucoma	7.31e-05	0.000361	CcSEcCtD
Methotrexate—Chest pain—Timolol—glaucoma	7.29e-05	0.00036	CcSEcCtD
Methotrexate—Arthralgia—Timolol—glaucoma	7.29e-05	0.00036	CcSEcCtD
Methotrexate—Myalgia—Timolol—glaucoma	7.29e-05	0.00036	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	7.24e-05	0.000358	CcSEcCtD
Methotrexate—Hypersensitivity—Clonidine—glaucoma	7.24e-05	0.000358	CcSEcCtD
Methotrexate—Discomfort—Timolol—glaucoma	7.2e-05	0.000356	CcSEcCtD
Methotrexate—Asthenia—Clonidine—glaucoma	7.05e-05	0.000349	CcSEcCtD
Methotrexate—Feeling abnormal—Betaxolol—glaucoma	7.05e-05	0.000349	CcSEcCtD
Methotrexate—Confusional state—Timolol—glaucoma	7.04e-05	0.000348	CcSEcCtD
Methotrexate—Anaphylactic shock—Timolol—glaucoma	6.99e-05	0.000346	CcSEcCtD
Methotrexate—Pruritus—Clonidine—glaucoma	6.95e-05	0.000344	CcSEcCtD
Methotrexate—Infection—Timolol—glaucoma	6.94e-05	0.000343	CcSEcCtD
Methotrexate—Nervous system disorder—Timolol—glaucoma	6.85e-05	0.000339	CcSEcCtD
Methotrexate—Urticaria—Betaxolol—glaucoma	6.79e-05	0.000336	CcSEcCtD
Methotrexate—Skin disorder—Timolol—glaucoma	6.79e-05	0.000336	CcSEcCtD
Methotrexate—Body temperature increased—Betaxolol—glaucoma	6.76e-05	0.000334	CcSEcCtD
Methotrexate—Hyperhidrosis—Timolol—glaucoma	6.75e-05	0.000334	CcSEcCtD
Methotrexate—Diarrhoea—Clonidine—glaucoma	6.72e-05	0.000332	CcSEcCtD
Methotrexate—Anorexia—Timolol—glaucoma	6.66e-05	0.000329	CcSEcCtD
Methotrexate—Hypotension—Timolol—glaucoma	6.53e-05	0.000323	CcSEcCtD
Methotrexate—Dizziness—Clonidine—glaucoma	6.49e-05	0.000321	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Timolol—glaucoma	6.36e-05	0.000315	CcSEcCtD
Methotrexate—Insomnia—Timolol—glaucoma	6.32e-05	0.000312	CcSEcCtD
Methotrexate—Hypersensitivity—Betaxolol—glaucoma	6.3e-05	0.000312	CcSEcCtD
Methotrexate—Paraesthesia—Timolol—glaucoma	6.27e-05	0.00031	CcSEcCtD
Methotrexate—Vomiting—Clonidine—glaucoma	6.24e-05	0.000309	CcSEcCtD
Methotrexate—Dyspnoea—Timolol—glaucoma	6.23e-05	0.000308	CcSEcCtD
Methotrexate—Somnolence—Timolol—glaucoma	6.21e-05	0.000307	CcSEcCtD
Methotrexate—Rash—Clonidine—glaucoma	6.19e-05	0.000306	CcSEcCtD
Methotrexate—Dermatitis—Clonidine—glaucoma	6.19e-05	0.000306	CcSEcCtD
Methotrexate—Headache—Clonidine—glaucoma	6.15e-05	0.000304	CcSEcCtD
Methotrexate—Dyspepsia—Timolol—glaucoma	6.15e-05	0.000304	CcSEcCtD
Methotrexate—Asthenia—Betaxolol—glaucoma	6.14e-05	0.000303	CcSEcCtD
Methotrexate—Decreased appetite—Timolol—glaucoma	6.07e-05	0.0003	CcSEcCtD
Methotrexate—Pruritus—Betaxolol—glaucoma	6.05e-05	0.000299	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Timolol—glaucoma	6.03e-05	0.000298	CcSEcCtD
Methotrexate—Fatigue—Timolol—glaucoma	6.02e-05	0.000298	CcSEcCtD
Methotrexate—Pain—Timolol—glaucoma	5.97e-05	0.000295	CcSEcCtD
Methotrexate—Diarrhoea—Betaxolol—glaucoma	5.85e-05	0.000289	CcSEcCtD
Methotrexate—Nausea—Clonidine—glaucoma	5.83e-05	0.000289	CcSEcCtD
Methotrexate—Feeling abnormal—Timolol—glaucoma	5.76e-05	0.000285	CcSEcCtD
Methotrexate—Gastrointestinal pain—Timolol—glaucoma	5.71e-05	0.000283	CcSEcCtD
Methotrexate—Dizziness—Betaxolol—glaucoma	5.65e-05	0.00028	CcSEcCtD
Methotrexate—Urticaria—Timolol—glaucoma	5.55e-05	0.000274	CcSEcCtD
Methotrexate—Body temperature increased—Timolol—glaucoma	5.52e-05	0.000273	CcSEcCtD
Methotrexate—Abdominal pain—Timolol—glaucoma	5.52e-05	0.000273	CcSEcCtD
Methotrexate—Vomiting—Betaxolol—glaucoma	5.44e-05	0.000269	CcSEcCtD
Methotrexate—Rash—Betaxolol—glaucoma	5.39e-05	0.000267	CcSEcCtD
Methotrexate—Dermatitis—Betaxolol—glaucoma	5.39e-05	0.000266	CcSEcCtD
Methotrexate—Headache—Betaxolol—glaucoma	5.36e-05	0.000265	CcSEcCtD
Methotrexate—Hypersensitivity—Timolol—glaucoma	5.15e-05	0.000255	CcSEcCtD
Methotrexate—Nausea—Betaxolol—glaucoma	5.08e-05	0.000251	CcSEcCtD
Methotrexate—Asthenia—Timolol—glaucoma	5.01e-05	0.000248	CcSEcCtD
Methotrexate—Pruritus—Timolol—glaucoma	4.94e-05	0.000244	CcSEcCtD
Methotrexate—Diarrhoea—Timolol—glaucoma	4.78e-05	0.000236	CcSEcCtD
Methotrexate—Dizziness—Timolol—glaucoma	4.62e-05	0.000228	CcSEcCtD
Methotrexate—Vomiting—Timolol—glaucoma	4.44e-05	0.00022	CcSEcCtD
Methotrexate—Rash—Timolol—glaucoma	4.4e-05	0.000218	CcSEcCtD
Methotrexate—Dermatitis—Timolol—glaucoma	4.4e-05	0.000218	CcSEcCtD
Methotrexate—Headache—Timolol—glaucoma	4.38e-05	0.000216	CcSEcCtD
Methotrexate—Nausea—Timolol—glaucoma	4.15e-05	0.000205	CcSEcCtD
Methotrexate—FPGS—Disease—CDKN1B—glaucoma	2.37e-05	0.00025	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CAV1—glaucoma	2.36e-05	0.000249	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.36e-05	0.000248	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CTSA—glaucoma	2.35e-05	0.000248	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—glaucoma	2.35e-05	0.000247	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.35e-05	0.000247	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.35e-05	0.000247	CbGpPWpGaD
Methotrexate—PGD—Metabolism—MTHFR—glaucoma	2.34e-05	0.000247	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.34e-05	0.000246	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.3e-05	0.000242	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—NOS3—glaucoma	2.29e-05	0.000242	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—NOS3—glaucoma	2.29e-05	0.000242	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—VEGFA—glaucoma	2.29e-05	0.000241	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—glaucoma	2.29e-05	0.000241	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.28e-05	0.00024	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—TXN—glaucoma	2.27e-05	0.000239	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.24e-05	0.000236	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CA2—glaucoma	2.22e-05	0.000234	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GSTT1—glaucoma	2.22e-05	0.000234	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—MMP1—glaucoma	2.21e-05	0.000233	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.2e-05	0.000232	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CDKN2B—glaucoma	2.2e-05	0.000232	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ABCA1—glaucoma	2.19e-05	0.00023	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CYP1B1—glaucoma	2.19e-05	0.00023	CbGpPWpGaD
Methotrexate—PGD—Metabolism—APOE—glaucoma	2.18e-05	0.00023	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CDKN2A—glaucoma	2.18e-05	0.00023	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	2.18e-05	0.00023	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CAV1—glaucoma	2.16e-05	0.000228	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—glaucoma	2.16e-05	0.000228	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NOS3—glaucoma	2.15e-05	0.000227	CbGpPWpGaD
Methotrexate—AOX1—Disease—CDKN2B—glaucoma	2.15e-05	0.000227	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CYP1B1—glaucoma	2.14e-05	0.000225	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ABCA1—glaucoma	2.14e-05	0.000225	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS3—glaucoma	2.13e-05	0.000225	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GSTT1—glaucoma	2.13e-05	0.000224	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—glaucoma	2.13e-05	0.000224	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—CAV1—glaucoma	2.12e-05	0.000224	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—PTGS2—glaucoma	2.1e-05	0.000221	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—PTGS2—glaucoma	2.1e-05	0.000221	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.07e-05	0.000218	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HDAC9—glaucoma	2.06e-05	0.000217	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.05e-05	0.000216	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.02e-05	0.000213	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—FN1—glaucoma	2.02e-05	0.000213	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.02e-05	0.000212	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—glaucoma	2.01e-05	0.000212	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TXN—glaucoma	1.98e-05	0.000208	CbGpPWpGaD
Methotrexate—DHFR—Disease—CDKN2B—glaucoma	1.96e-05	0.000206	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GSTT1—glaucoma	1.95e-05	0.000206	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS3—glaucoma	1.95e-05	0.000206	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTGS2—glaucoma	1.95e-05	0.000206	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ABCA1—glaucoma	1.94e-05	0.000205	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CYP1B1—glaucoma	1.94e-05	0.000205	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CDKN1B—glaucoma	1.93e-05	0.000203	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CDKN2A—glaucoma	1.9e-05	0.0002	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—glaucoma	1.88e-05	0.000199	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CDKN1B—glaucoma	1.85e-05	0.000195	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.84e-05	0.000194	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—glaucoma	1.82e-05	0.000191	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.8e-05	0.00019	CbGpPWpGaD
Methotrexate—AOX1—Disease—MTHFR—glaucoma	1.8e-05	0.00019	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.79e-05	0.000188	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NOS3—glaucoma	1.79e-05	0.000188	CbGpPWpGaD
Methotrexate—PGD—Disease—PTGS2—glaucoma	1.78e-05	0.000188	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TXN—glaucoma	1.78e-05	0.000188	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	1.77e-05	0.000187	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CYP1B1—glaucoma	1.77e-05	0.000187	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ABCA1—glaucoma	1.77e-05	0.000187	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GSTT1—glaucoma	1.76e-05	0.000186	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GSTM1—glaucoma	1.75e-05	0.000184	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—glaucoma	1.73e-05	0.000183	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB2—glaucoma	1.73e-05	0.000183	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.72e-05	0.000182	CbGpPWpGaD
Methotrexate—MTHFR—Disease—APOE—glaucoma	1.72e-05	0.000181	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GSTM1—glaucoma	1.71e-05	0.00018	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CAV1—glaucoma	1.7e-05	0.000179	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYP1B1—glaucoma	1.7e-05	0.000179	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ABCA1—glaucoma	1.7e-05	0.000179	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TXN—glaucoma	1.69e-05	0.000178	CbGpPWpGaD
Methotrexate—PGD—Disease—CDKN1B—glaucoma	1.69e-05	0.000178	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CDKN1B—glaucoma	1.68e-05	0.000178	CbGpPWpGaD
Methotrexate—AOX1—Disease—APOE—glaucoma	1.68e-05	0.000177	CbGpPWpGaD
Methotrexate—AOX1—Disease—CAV1—glaucoma	1.66e-05	0.000175	CbGpPWpGaD
Methotrexate—DHFR—Disease—MTHFR—glaucoma	1.64e-05	0.000173	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTGS2—glaucoma	1.63e-05	0.000172	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NOS3—glaucoma	1.63e-05	0.000172	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.62e-05	0.000171	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.61e-05	0.00017	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.61e-05	0.00017	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS3—glaucoma	1.6e-05	0.000169	CbGpPWpGaD
Methotrexate—MTHFR—Disease—BAD—glaucoma	1.6e-05	0.000169	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.57e-05	0.000166	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TXN—glaucoma	1.57e-05	0.000165	CbGpPWpGaD
Methotrexate—AOX1—Disease—BAD—glaucoma	1.56e-05	0.000165	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP1B1—glaucoma	1.56e-05	0.000164	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ABCA1—glaucoma	1.56e-05	0.000164	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GSTM1—glaucoma	1.55e-05	0.000164	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—VEGFA—glaucoma	1.55e-05	0.000163	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.54e-05	0.000163	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTT1—glaucoma	1.53e-05	0.000162	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.53e-05	0.000161	CbGpPWpGaD
Methotrexate—DHFR—Disease—APOE—glaucoma	1.53e-05	0.000161	CbGpPWpGaD
Methotrexate—DHFR—Disease—CAV1—glaucoma	1.51e-05	0.000159	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—MTHFR—glaucoma	1.51e-05	0.000159	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CA1—glaucoma	1.5e-05	0.000158	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTGS2—glaucoma	1.49e-05	0.000157	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CTSA—glaucoma	1.45e-05	0.000153	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—APOE—glaucoma	1.44e-05	0.000152	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CAV1—glaucoma	1.42e-05	0.00015	CbGpPWpGaD
Methotrexate—DHFR—Disease—BAD—glaucoma	1.42e-05	0.00015	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.42e-05	0.00015	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GSTM1—glaucoma	1.41e-05	0.000149	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—APOE—glaucoma	1.4e-05	0.000148	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP1B1—glaucoma	1.4e-05	0.000148	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ABCA1—glaucoma	1.4e-05	0.000148	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CAV1—glaucoma	1.39e-05	0.000147	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTT1—glaucoma	1.38e-05	0.000145	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—MTHFR—glaucoma	1.37e-05	0.000145	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CA2—glaucoma	1.37e-05	0.000145	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GSTM1—glaucoma	1.36e-05	0.000143	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.34e-05	0.000141	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.34e-05	0.000141	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CA1—glaucoma	1.31e-05	0.000138	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SOD1—glaucoma	1.31e-05	0.000138	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTT1—glaucoma	1.31e-05	0.000138	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS3—glaucoma	1.29e-05	0.000136	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—APOE—glaucoma	1.28e-05	0.000135	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CTSA—glaucoma	1.27e-05	0.000134	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.27e-05	0.000134	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CAV1—glaucoma	1.27e-05	0.000133	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS3—glaucoma	1.26e-05	0.000132	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MTHFR—glaucoma	1.25e-05	0.000132	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GSTM1—glaucoma	1.24e-05	0.000131	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.24e-05	0.00013	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP1B1—glaucoma	1.22e-05	0.000129	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ABCA1—glaucoma	1.22e-05	0.000129	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTT1—glaucoma	1.21e-05	0.000128	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—glaucoma	1.21e-05	0.000128	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CA2—glaucoma	1.2e-05	0.000127	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.2e-05	0.000127	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MTHFR—glaucoma	1.2e-05	0.000126	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—glaucoma	1.18e-05	0.000124	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—glaucoma	1.17e-05	0.000123	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—APOE—glaucoma	1.16e-05	0.000123	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—VEGFA—glaucoma	1.16e-05	0.000122	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CAV1—glaucoma	1.15e-05	0.000122	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—glaucoma	1.15e-05	0.000121	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—glaucoma	1.14e-05	0.00012	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GSTM1—glaucoma	1.12e-05	0.000118	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—APOE—glaucoma	1.12e-05	0.000118	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CDKN1B—glaucoma	1.11e-05	0.000117	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.11e-05	0.000117	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CDKN2B—glaucoma	1.11e-05	0.000117	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CAV1—glaucoma	1.1e-05	0.000116	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ABCA1—glaucoma	1.1e-05	0.000116	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP1B1—glaucoma	1.1e-05	0.000116	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MTHFR—glaucoma	1.1e-05	0.000116	CbGpPWpGaD
Methotrexate—AOX1—Disease—CDKN1B—glaucoma	1.09e-05	0.000115	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—glaucoma	1.08e-05	0.000114	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—glaucoma	1.06e-05	0.000112	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.06e-05	0.000111	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—glaucoma	1.05e-05	0.000111	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—glaucoma	1.05e-05	0.00011	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ABCA1—glaucoma	1.04e-05	0.00011	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP1B1—glaucoma	1.04e-05	0.00011	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOE—glaucoma	1.02e-05	0.000108	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.01e-05	0.000107	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CAV1—glaucoma	1.01e-05	0.000107	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—MMP1—glaucoma	1e-05	0.000105	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	9.99e-06	0.000105	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MTHFR—glaucoma	9.91e-06	0.000104	CbGpPWpGaD
Methotrexate—DHFR—Disease—CDKN1B—glaucoma	9.9e-06	0.000104	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—glaucoma	9.85e-06	0.000104	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTM1—glaucoma	9.77e-06	0.000103	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ABCA1—glaucoma	9.68e-06	0.000102	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP1B1—glaucoma	9.68e-06	0.000102	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TXN—glaucoma	9.66e-06	0.000102	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—glaucoma	9.62e-06	0.000101	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CAV1—glaucoma	9.6e-06	0.000101	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—glaucoma	9.57e-06	0.000101	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTHFR—glaucoma	9.28e-06	9.78e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOE—glaucoma	9.23e-06	9.73e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CAV1—glaucoma	9.14e-06	9.64e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—FN1—glaucoma	9.13e-06	9.63e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.82e-06	9.29e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTM1—glaucoma	8.79e-06	9.26e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—glaucoma	8.76e-06	9.23e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.74e-06	9.21e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—glaucoma	8.73e-06	9.2e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—glaucoma	8.72e-06	9.19e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOE—glaucoma	8.64e-06	9.1e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTHFR—glaucoma	8.63e-06	9.1e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.56e-06	9.02e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CAV1—glaucoma	8.56e-06	9.02e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TXN—glaucoma	8.47e-06	8.92e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—glaucoma	8.35e-06	8.8e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTM1—glaucoma	8.35e-06	8.8e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—BAD—glaucoma	8.05e-06	8.48e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOE—glaucoma	8.04e-06	8.47e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—glaucoma	7.98e-06	8.41e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CAV1—glaucoma	7.96e-06	8.39e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTHFR—glaucoma	7.77e-06	8.19e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTM1—glaucoma	7.73e-06	8.15e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—glaucoma	7.66e-06	8.08e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—glaucoma	7.64e-06	8.05e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.55e-06	7.95e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTT1—glaucoma	7.49e-06	7.9e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—glaucoma	7.38e-06	7.78e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—glaucoma	7.26e-06	7.65e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOE—glaucoma	7.23e-06	7.62e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CAV1—glaucoma	7.17e-06	7.55e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—glaucoma	7.01e-06	7.39e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—glaucoma	6.91e-06	7.29e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOE—glaucoma	6.87e-06	7.24e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—glaucoma	6.84e-06	7.2e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CAV1—glaucoma	6.81e-06	7.18e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTT1—glaucoma	6.57e-06	6.92e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—glaucoma	6.47e-06	6.82e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOE—glaucoma	6.36e-06	6.71e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—glaucoma	6.32e-06	6.67e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CAV1—glaucoma	6.31e-06	6.65e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.04e-06	6.37e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—glaucoma	6.02e-06	6.35e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP1B1—glaucoma	5.97e-06	6.29e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCA1—glaucoma	5.97e-06	6.29e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—glaucoma	5.92e-06	6.24e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CDKN1B—glaucoma	5.6e-06	5.91e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—glaucoma	5.51e-06	5.8e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—glaucoma	5.42e-06	5.71e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP1B1—glaucoma	5.23e-06	5.51e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCA1—glaucoma	5.23e-06	5.51e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VEGFA—glaucoma	5.23e-06	5.51e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—glaucoma	5.15e-06	5.43e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—glaucoma	4.96e-06	5.22e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTM1—glaucoma	4.77e-06	5.03e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—glaucoma	4.77e-06	5.03e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—glaucoma	4.71e-06	4.96e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—glaucoma	4.36e-06	4.6e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—glaucoma	4.22e-06	4.45e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTM1—glaucoma	4.18e-06	4.41e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—glaucoma	3.95e-06	4.16e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOE—glaucoma	3.93e-06	4.14e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CAV1—glaucoma	3.89e-06	4.1e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—glaucoma	3.7e-06	3.9e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOE—glaucoma	3.44e-06	3.63e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CAV1—glaucoma	3.41e-06	3.59e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—glaucoma	2.94e-06	3.1e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—glaucoma	2.69e-06	2.84e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—glaucoma	2.58e-06	2.72e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—glaucoma	2.36e-06	2.48e-05	CbGpPWpGaD
